STEEPLE bleeding criteria

Bleeding Microchapters
Home
Patient Information
Overview
Classification
Bleeding Academic Research Consortium
TIMI bleeding criteria
GUSTO bleeding criteria
CURE bleeding criteria
ACUITY HORIZONS bleeding criteria
STEEPLE bleeding criteria
PLATO bleeding criteria
GRACE bleeding criteria
Causes
Treatment
Emergency Bleeding Control
Reversal of Anticoagulation and Antiplatelet in Active Bleed
Perioperative Bleeding
Anemia Management
Coagulation Monitoring
Coagulation Management
Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy Antiplatelet Agents Heparin Fondaparinux Vitamin K Antagonists New Oral Anticoagulants Comorbidities Involving Hemostatic Derangement
Specific Surgeries Cardiovascular Surgery Gynecological Bleeding Obstetric Bleeding Orthopedic/Neurosurgery Visceral/Transplant Surgery Pediatric Surgery
Congenital Bleeding Disorders von Willebrand Disease Platelet Defects Hemophilia A and B Factor VII Deficiency Rare Bleeding Disorders
STEEPLE bleeding criteria On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of STEEPLE bleeding criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on STEEPLE bleeding criteria
CDC on STEEPLE bleeding criteria
STEEPLE bleeding criteria in the news
Blogs on STEEPLE bleeding criteria
Directions to Hospitals Treating Bleeding
Risk calculators and risk factors for STEEPLE bleeding criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Steeple Bleeding Criteria (DO NOT EDIT)

“

Safety and Efficacy Of Enoxaparin In Percutaneous Coronary Intervention Patients: An International Randomized Evaluation Major Bleeding Fatal bleeding Retroperitoneal, intracranial, or intraocular bleeding Bleeding that causes hemodynamic compromise requiring specific treatment Bleeding that requires intervention (surgical or endoscopic) or decompression of a closed space to stop or control the event Clinically overt bleeding, requiring any transfusion of ≥1 U PRBC or whole blood Clinically overt bleeding, causing a decrease in hemoglobin of ≥3 g/dL (or, if hemoglobin level is not available, a decrease in hematocrit of ≥10%) Minor Gross hematuria not associated with trauma (eg, from instrumentation) Epistaxis that is prolonged, is repeated, or requires plugging or intervention Gastrointestinal hemorrhage Hemoptysis Subconjunctival hemorrhage Hematoma >5 cm or leading to prolonged or new hospitalization Clinically overt bleeding, causing a decrease in hemoglobin of 2 to 3 g/dL Uncontrolled bleeding requiring protamine sulfate administration

”